Industry Financials
How to evaluate financials of a company in the Pharmaceuticals and biotechnology industry?
1. Review the Company's Financial Statements: Start by reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement. These documents will give you a comprehensive overview of the company's financial health and performance over time.
2. Analyze Revenue and Profit Margins: The pharmaceuticals and biotechnology industry is highly competitive, so it's important to look at the company's revenue and profit margins. Compare the revenue growth and profitability of the company over the past few years to understand its market position.
3. Examine Research and Development (R&D) expenses: In the pharmaceuticals and biotechnology industry, R&D is a critical key to success. Check the amount of money the company invests in R&D and how much of its revenue is allocated to R&D. This will give you an understanding of the company's pipeline of new drugs or products and its potential for future growth.
4. Look at Patent Portfolio: Patents are critical for pharmaceutical and biotech companies as they protect their products and allow them to charge premium prices. Look at the company's patent portfolio to assess the strength of its intellectual property and the potential for future product developments.
5. Analyze Debt and Cash Flow: Check the company's debt levels and cash flow to see if it has enough liquidity to fund ongoing R&D and operations. A high level of debt could be a warning sign, while a strong cash flow will indicate that the company is in a good position to finance new projects.
6. Evaluate Market and Competition: Understand the market dynamics and competition in the pharmaceutical and biotechnology industry to assess the company's competitive advantage. Look at the company's market share, product differentiation, and barriers to entry to determine its long-term potential for growth and profitability.
7. Assess Regulatory Environment: The pharmaceutical and biotech industry is heavily regulated, and changes in regulations or approvals for new products can significantly impact a company's financials. Stay updated on the regulatory landscape and evaluate the company's strategies to comply with regulations and navigate potential changes effectively.
8. Consider Mergers and Acquisitions: Mergers and acquisitions are common in the pharmaceutical and biotechnology industry, as companies look to expand their product portfolio and pipelines. Look at the company's history of acquisitions and analyze how it has impacted its financials.
9. Conduct a SWOT Analysis: A SWOT analysis of the company will help identify its strengths, weaknesses, opportunities, and threats. It can provide valuable insights into the company's financial performance and highlight any potential risks.
10. Consult with Financial Experts: If you are not familiar with the industry or financial analysis, it is advisable to seek the guidance of financial experts. They can help you interpret the financial data and provide a deeper understanding of the company's financials.
What are the cost structures and profit margins in the Pharmaceuticals and biotechnology industry?
The cost structure of the Pharmaceuticals and biotechnology industry is mainly driven by research and development (R&D) expenses, marketing and advertising, manufacturing, and administrative costs.
R&D expenses are a significant component of the cost structure in the pharmaceutical and biotechnology industry. Pharmaceutical companies invest a significant amount of money in research and development to discover and develop new drugs and biotechnology products. These costs include salaries and benefits for scientists and researchers, laboratory and equipment costs, clinical trials, and costs associated with obtaining regulatory approvals.
Marketing and advertising expenses also contribute to the cost structure of the pharmaceutical and biotechnology industry. These include promotional activities such as direct-to-consumer advertising, physician advertising, and sponsorship of medical conferences.
The manufacturing cost is another crucial component of the cost structure in this industry. Pharmaceutical companies have high fixed costs associated with manufacturing facilities and equipment, as well as the costs of sourcing raw materials and maintaining quality control.
Administrative expenses, such as salaries and benefits for management and administrative staff, also contribute to the cost structure in this industry.
The profit margins in the pharmaceutical and biotechnology industry can vary significantly depending on the company, product mix, and other factors. Generally, pharmaceutical companies have higher profit margins than biotechnology companies. However, both sectors are highly competitive, and profit margins can be subject to fluctuations due to patent expirations, competition, and changes in regulations.
Pharmaceutical companies typically have higher profit margins due to their brand name drugs, which often have higher prices and longer patent life than biotechnology products. On the other hand, biotechnology companies may have higher R&D and marketing costs associated with launching new products, resulting in lower profit margins.
In recent years, pharmaceutical and biotechnology companies have faced increasing pressure from governments, insurance companies, and consumers to control drug prices, which can also affect profit margins in the industry.
What is the size of the Pharmaceuticals and biotechnology industry in terms of revenue and market share?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
How do fluctuations in input costs or external factors impact the Pharmaceuticals and biotechnology industry economics?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
What are the big costs in the Pharmaceuticals and biotechnology industry?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
What was the average P/E ratio at the Pharmaceuticals and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
What was the average Dividend Payout Ratio ratio at the Pharmaceuticals and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
What was the average Return on Sales ratio at the Pharmaceuticals and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
What was the average Return on Assets ratio at the Pharmaceuticals and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
What was the average Return on Equity ratio at the Pharmaceuticals and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
What was the average Gross Margin at the Pharmaceuticals and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
What was the average Operating Margin at the Pharmaceuticals and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9HTldHc1lS TnZpU0lmWGtmakdqZy53 ZWJwIiBhbHQ9IlBmaXpl ciIgdGl0bGU9IlBmaXpl ciIgY2xhc3M9ImltZy1m bHVpZCIgaGVpZ2h0PTkw IHdpZHRoPTkwIGxvYWRp bmc9J2xhenknPgoKICAg ICAgICAgICAgICAgICAg ICA8ZGl2IHN0eWxlPSdm bGV4OiAxOyB0ZXh0LWFs aWduOiBjZW50ZXI7IG1h cmdpbi1sZWZ0OiA1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgPHAg c3R5bGU9J2ZvbnQtc2l6 ZTogMjZweDsgY29sb3I6 ICMzMzM7IG1hcmdpbi1i b3R0b206IDE1cHg7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIFdh bnQgdG8gcmVhZCBtb3Jl IGFib3V0IFBmaXplcj8K ICAgICAgICAgICAgICAg ICAgICAgICAgPC9wPgoK ICAgICAgICAgICAgICAg ICAgICAgICAgPGEgaHJl Zj0naW5kZXgucGhwP3Bh Z2U9c2lnbnVwJyBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBiYWNrZ3JvdW5kLWNv bG9yOiAjMDA3QkZGOwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICNmZmY7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBwYWRkaW5n OiAxMHB4IDIwcHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICBib3Jk ZXItcmFkaXVzOiA1cHg7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IG5vbmU7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBmb250LXdlaWdo dDogYm9sZDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG1hcmdpbi1y aWdodDogMTBweDsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIHRyYW5z aXRpb246IGJhY2tncm91 bmQtY29sb3IgMC4zcyBl YXNlOycKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdmVy PSd0aGlzLnN0eWxlLmJh Y2tncm91bmRDb2xvcj0i IzAwNTZiMyIKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIG9ubW91c2Vv dXQ9J3RoaXMuc3R5bGUu YmFja2dyb3VuZENvbG9y PSIjMDA3QkZGIj4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIFNpZ24g dXAgZm9yIGZyZWUKICAg ICAgICAgICAgICAgICAg ICAgICAgPC9hPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPHNwYW4gc3R5 bGU9J21hcmdpbjogMCA4 cHg7IGNvbG9yOiAjNTU1 Oyc+b3I8L3NwYW4+Cgog ICAgICAgICAgICAgICAg ICAgICAgICA8YSBocmVm PSdpbmRleC5waHA/cGFn ZT1sb2dpbicgc3R5bGU9 JwogICAgICAgICAgICAg ICAgICAgICAgICAgICAg Y29sb3I6ICMwMDdCRkY7 CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICB0 ZXh0LWRlY29yYXRpb246 IHVuZGVybGluZTsKICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGZvbnQt d2VpZ2h0OiA1MDA7Jz4K ICAgICAgICAgICAgICAg ICAgICAgICAgICAgIGxv ZyBpbgogICAgICAgICAg ICAgICAgICAgICAgICA8 L2E+CiAgICAgICAgICAg ICAgICAgICAgPC9kaXY+ CiAgICAgICAgICAgICAg ICA8L2Rpdj4KICAgICAg ICAgICAgPC9kaXY+Cgog ICAgICAgICAgICA=
